Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Vital Therapies Secures $16 Million for Trial of Artificial Liver Device

publication date: Oct 3, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Vital Therapies, a San Diego company that is developing a device to treat liver failure, has closed a $16 million capital round from its existing investors, the first of a planned $76 million multi-stage commitment. Last year, Vital Therapies raised $2 million from Jilin Aodong Medicine and was slated to receive an additional $25 million in six months if Vital Therapies was successful in obtaining SFDA approval of its device. The approval was not secured. More details....

Stock Symbol: (SHE: 000623)

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...



Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China

>>More events...
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Partners